Published in:
01-06-2022 | Heart Failure | Original Article
Fibrillation cycle length predicts cardiovascular events in patients with long-standing persistent atrial fibrillation
Authors:
Hironori Nakamura, Shinichi Niwano, Hidehira Fukaya, Jun Kishihara, Akira Satoh, Jun Oikawa, Tomoharu Yoshizawa, Naruya Ishizue, Tazuru Igarashi, Tamami Fujiishi, Ryo Nishinarita, Ai Horiguchi, Junya Ako
Published in:
Heart and Vessels
|
Issue 6/2022
Login to get access
Abstract
Background
Atrial fibrillation (AF) is associated with an increased risk of heart failure (HF), stroke, and death. Although fibrillation cycle length (FCL) is used as a surrogate for atrial refractoriness, its impact on outcomes remains unclear. This study aimed to identify predictors of cardiovascular events, including FCL, in patients with long-standing persistent AF.
Methods
The study included 190 consecutive patients with long-standing persistent AF (mean age 74 years, 74% male). Patients with valvular AF or hemodialysis-dependent end-stage renal disease and those on anti-arrhythmic drugs were excluded. The primary composite outcome was occurrence of cardiovascular events (myocardial infarction, HF), cerebrovascular events (stroke, transient ischemic attack), and all-cause death. FCL was calculated by fast Fourier transformation analysis of fibrillation waves in the surface electrocardiogram.
Results
Over a median follow-up of 2.6 years, the primary outcome occurred in 31 patients (cardiovascular events, n = 18; cerebrovascular events, n = 8; all-cause death, n = 5). In multivariate analysis, longer FCL and history of HF were independent predictors of these outcomes. In a Cox proportional hazards model adjusted for age, sex, and history of HF, patients with an FCL > 160 ms (cut-off determined by receiver-operating characteristic curve analysis) were at increased risk of the outcome (hazard ratio 12.9; 95% confidence interval 4.99–44.10; p < 0.001).
Conclusions
FCL was independently associated with cardiovascular outcomes in patients with long-standing persistent AF.